University of Texas's MD Anderson Cancer Center: Tumor-infiltrating B cells and plasma cells influence early-stage lung cancer biology, immunotherapy responses
September 14, 2022
September 14, 2022
HOUSTON, Texas, Sept. 14 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 13, 2022:
* * *
Single-cell study provides valuable resource to identify new immunotherapy strategies
* * *
Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung canc . . .
* * *
Single-cell study provides valuable resource to identify new immunotherapy strategies
* * *
Through extensive single-cell analysis, researchers at The University of Texas MD Anderson Cancer Center have created a spatial map of tumor-infiltrating B cells and plasma cells in early-stage lung canc . . .